These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7441647)

  • 1. Muramyl dipeptide stimulation of particle clearance in several animal species.
    Waters RV; Ferraresi RW
    J Reticuloendothel Soc; 1980 Nov; 28(5):457-71. PubMed ID: 7441647
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of tumoricidal properties in murine macrophages by intravenous injection of muramyl dipeptide encapsulated within liposomes as a treatment for spontaneous metastasis.
    Fidler IJ; Poste G
    Prog Clin Biol Res; 1981; 75B():257-67. PubMed ID: 7323097
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.
    Fraser-Smith EB; Waters RV; Matthews TR
    Infect Immun; 1982 Jan; 35(1):105-10. PubMed ID: 7054119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
    Audibert F; Chedid L
    Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of bestatin and muramyl-dipeptide on macrophage-bound aminopeptidase.
    Wachsmuth ED; Wüst B
    Hoppe Seylers Z Physiol Chem; 1981 May; 362(5):563-8. PubMed ID: 7250904
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reticuloendothelial system activation using synthetic glycopeptides in the mouse (author's transl)].
    Hlavatá D; Masek K
    Cas Lek Cesk; 1981 Jun; 120(22):662-4. PubMed ID: 7237508
    [No Abstract]   [Full Text] [Related]  

  • 7. The in situ induction of tumoricidal activity in alveolar macrophages by liposomes containing muramyl dipeptide is a thymus-independent process.
    Fidler IJ
    J Immunol; 1981 Oct; 127(4):1719-20. PubMed ID: 6974201
    [No Abstract]   [Full Text] [Related]  

  • 8. Dissociation of immunostimulant activities of muramyl dipeptide (MDP) by linking amino-acids or peptides to the glutaminyl residue.
    Audibert F; Parant M; Damais C; Lefrancier P; Derrien M; Choay J; Chedid L
    Biochem Biophys Res Commun; 1980 Sep; 96(2):915-23. PubMed ID: 7426019
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of novel derivatives of muramyl dipeptide on the immune system].
    Kaliuzhin OV; Fuks BB; Bovin NV; Zemliakov AE; Chirva VIa
    Biull Eksp Biol Med; 1994 May; 117(5):510-3. PubMed ID: 9296705
    [No Abstract]   [Full Text] [Related]  

  • 10. Macrophage activation by muramyl dipeptide as measured by macrophage spreading and attachment.
    Tanaka A; Nagao S; Imai K; Mori R
    Microbiol Immunol; 1980; 24(6):547-57. PubMed ID: 7412595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation by muramyl dipeptide (MDP) without lymphocyte participation.
    Nagao S; Miki T; Tanaka A
    Microbiol Immunol; 1981; 25(1):41-50. PubMed ID: 7253958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.
    Tanaka A; Nagao S; Nagao R; Kotani S; Shiba T; Kusumoto S
    Infect Immun; 1979 May; 24(2):302-7. PubMed ID: 457275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-specific MIF-like activity induced by the synthetic immunoadjuvant: N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP).
    Adam A; Souvannavong V; Lederer E
    Biochem Biophys Res Commun; 1978 Nov; 85(2):684-90. PubMed ID: 367370
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fundamental studies to use the adjuvant activity of 6-o-acylmuramyldipeptides to potentiate cell and humoral immune responses for practical purposes].
    Tsujimoto M
    J Osaka Univ Dent Sch; 1981 Jun; 26(1):63-83. PubMed ID: 6945426
    [No Abstract]   [Full Text] [Related]  

  • 15. Augmentation of mouse natural killer cell activity by muramyl dipeptide and its analogs.
    Sharma SD; Tsai V; Krahenbuhl JL; Remington JS
    Cell Immunol; 1981 Jul; 62(1):101-9. PubMed ID: 7261067
    [No Abstract]   [Full Text] [Related]  

  • 16. Muramyl dipeptide enhances in vitro peritoneal macrophage phagocytic activity.
    McCoy DM; Brown GL; Ausobsky JR; Polk HC
    Am Surg; 1985 Nov; 51(11):634-6. PubMed ID: 4062058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species variability for toxicity of free and liposome-encapsulated muramyl peptides administered intravenously.
    Fidler IJ; Brown NO; Hart IR
    J Biol Response Mod; 1985 Jun; 4(3):298-309. PubMed ID: 4020387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of the mitogenicity of muramyl dipeptide.
    Wood DD; Staruch MJ
    Int J Immunopharmacol; 1981; 3(1):31-44. PubMed ID: 6975247
    [No Abstract]   [Full Text] [Related]  

  • 19. Release of superoxide anion and enhanced candidacidal activity as a manifestation of macrophage activation: studies with muramyl dipeptide.
    Cummings NP; Pabst MJ; Johnston RB
    Adv Exp Med Biol; 1982; 141():179-87. PubMed ID: 6283823
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of synthetic muramyl dipeptide (MDP) on differentition of myeloid leukemic cells.
    Akagawa KS; Tokunaga T
    Microbiol Immunol; 1980; 24(10):1005-11. PubMed ID: 6936604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.